Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Introduces PureEpi™ Chromatin Preparation and Optimization Kit

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Optimized for preparation of chromatin samples specifically for the Chromatin Immunoprecipitation (ChIP) application.

Merck Millipore has introduced the PureEpi™ Chromatin Preparation and Optimization Kit. The PureEpi™ kit provides a systematic approach to address the technical challenges of optimizing the preparation of chromatin by providing a complete set of validated reagents specifically designed for the generation of chromatin for ChIP experiments.

The materials provided in this kit are ideal for both the optimization of chromatin preparations, as well as the generation of chromatin in multiple sample types starting from either cultured cells or tissues.

"ChIP and ChIP-seq are two very powerful techniques used to study how changes in chromatin structure impact gene expression. The successful performance of these techniques relies on high quality chromatin to produce meaningful data," says Michael Sturges, Ph.D., Senior Product Manager, Epigenetics, Merck Millipore.

Sturges continued, "New users of the ChIP application often struggle initially to establish reliable working protocols for chromatin preparation. For many laboratories, the chromatin preparation step of ChIP can be technically demanding, as it requires accounting for multiple variables that are unique to each experimental situation. Any lab that needs a reliable and reproducible approach to generate high quality chromatin that gives the best possible ChIP signal will benefit from the PureEpi™ kit."

During development of the PureEpi™ kit, the R&D team at Merck Millipore conducted numerous experiments to explore how different variables in chromatin preparation impact a ChIP experiment.

Parameters such as chromatin size, input cell numbers, fixation, sonication, and sample type all impact the quality of the chromatin and consequently the ChIP data.

The protocols and reagents developed as a result of this investigation have been incorporated into these kits to enable any lab to establish conditions that generate highly ChIPable chromatin.

While other kits enable extraction of chromatin from cells, this is the first kit to provide a set of buffers, detailed methods and optimization guidelines specifically designed for generation of sheared chromatin for ChIP.

The protocol provided in the kit outlines a standard approach for chromatin preparation and includes tips to avoid common pitfalls.

Additional sections with data demonstrating how modifications to key parameters such as fixation and sonication conditions impact chromatin quality and ChIP performance are presented to help guide optimization for more challenging experiments.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Agreement with Precision Biologics
Merck Millipore services include design and development of cost-effective process to deliver high yield and productivity.
Thursday, February 05, 2015
Merck Millipore Partners with Gyros
Partnership to develop, manufacture and commercialize kits on the Gyrolab™ immunoassay platform.
Tuesday, July 16, 2013
Merck Millipore Announces Partnership with NIH Consortium
Adds more than 140 peer-validated neuroscience-specific monoclonal antibodies to portfolio.
Tuesday, October 16, 2012
Scientific News
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!